Cited by 120Alzheimer's disease research and treatmentsMitochondrial Function and PathologyDementia and Cognitive Impairment Research

Molecular Basis of Alzheimer’s Disease: Focus on Mitochondria

Oliver, Darryll M.A., Reddy, P. Hemachandra·2019·Journal of Alzheimer s Disease

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by memory loss and multiple cognitive impairments. With the increased aging population, AD is a major health concern in society. Morphological and pathological studies revealed that AD is associated with the loss of synapses, defective mitochondria, and the proliferation of reactive astrocytes and microglia, in addition to the presence amyloid-β and phosphorylated tau in learning and memory regions of the brain in AD patients. AD occurs in two forms: early-onset familial and late-onset sporadic. Genetic mutations in APP, PS1, and PS2 loci cause familial AD. Multiple factors are reported to be involved in late-onset AD, including APOE4 genotype, polymorphisms in several gene loci and type 2 diabetes, traumatic brain injury, stroke, and age-related factors, including increased reactive oxygen species production and dysfunction in mitochondria. It is widely accepted that synaptic damage and mitochondrial dysfunction are early events in disease process. The purpose of this article is to highlight molecular triggers to the disease process. This article also reviews factors, including age, gender, lifestyle, epigenetic factors, and type 2 diabetes, that are involved in late-onset AD. This article also discusses recent developments in research of mitochondrial structure, function, physiology, dynamics, biogenesis, mitophagy, and mitochondrial DNA changes in healthy and diseased states.

Integrity signals

Registry

Crossref · 10.3233/jad-190048

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • S-Nitrosylation of the GTPase activity region of Drp-1 leads to loss of activity and, in a mutant APP/PS1 transgenic mouse model of AD, leads to neurotoxicity.

    “Among the various PTMs, S-Nitrosylation of the GTPase activity region of Drp-1 leads to a loss of activity and in a mutant APP/PS1 transgenic mouse model of AD, it leads to neurotoxicity [39].”
  • Drp-1 is critically important for mitochondrial fission, but when its expression is lowered, there is some evidence that Drp-1 may play a role in mitochondrial fusion as well.

    “Drp-1 is critically important for mitochondrial fission, but when its expression is lowered, there is some evidence that Drp-1 may play a role in mitochondria fusion as well [39].”

Cites

3 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Oliver, D. M. A., & Reddy, P. H.
Affiliations
Texas Tech University (US)
Corresponding author
Reddy, P. Hemachandra
Venue
Journal of Alzheimer s Disease
Published
2019-12-27
Volume
72
Issue
s1
Pages
S95-S116
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2923937720
Cited by
120
References
67
Citations by year
2026: 10 · 2025: 17 · 2024: 18 · 2023: 12 · 2022: 18 · 2021: 18 · 2020: 21 · 2019: 6
FWCI
1.85
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (R41AG060836, R01AG042178, R01AG047812)
  • National Institute of Neurological Disorders and Stroke (R01NS105473)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, mitochondrial dysfunction
MeSH terms
Alzheimer Disease, Animals, Brain, DNA, Mitochondrial, Humans, Mitochondria, Phosphorylation, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review